Dioxaphetyl butyrate
 | |
| Systematic (IUPAC) name | |
|---|---|
|
Ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate | |
| Clinical data | |
| Legal status | |
| Routes of administration | Oral, Other ROA Unknown |
| Identifiers | |
| CAS Number |
467-86-7  |
| ATC code | None |
| PubChem | CID 48194 |
| UNII |
G751H98FY4  |
| Synonyms | Amidalgon, Spasmoxal |
| Chemical data | |
| Formula | C22H27NO3 |
| Molar mass | 353.45 g/mol |
| |
| (what is this?) (verify) | |
Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.
It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.
In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregrate manufacturing quota of zero.
References
This article is issued from Wikipedia - version of the Monday, October 12, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.